Compounds that modulate Hsp90 activity and methods for identifying same

Details for Australian Patent Application No. 2007267852 (hide)

Owner Synta Pharmaceuticals Corp.

Inventors Ying, Weiwen

Agent Davies Collison Cave

Pub. Number AU-A-2007267852

PCT Pub. Number WO2007/139960

Priority 60/808,362 25.05.06 US

Filing date 25 May 2007

Wipo publication date 6 December 2007

International Classifications

C07D 249/12 (2006.01) Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms

C07D 405/06 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

29 January 2009 PCT application entered the National Phase

  PCT publication WO2007/139960 Priority application(s): WO2007/139960

10 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007267859-Triazole compounds that modulate Hsp90 activity

2007267847-Triazole compounds that modulate Hsp90 activity